Acquisition highlights of Pharmazz and a snapshot of its key metrics.

Founded in 2010, Pharmazz operates in Health Tech offering novel products in critical care medicine. The company has developed Centhaquine for hypovolemic shock and Sovateltide for cerebral ischemic stroke, both of which have received FDA approval for phase III INDs. In India, Pharmazz has secured marketing authorization for these first-in-class drug molecules and has partnered with Sun Pharmaceutical and Dr. Reddy s Laboratories to market them. The company s goal is to improve treatment options for patients experiencing critical health conditions. Additional information can be found on the companys website.

Anil Gulati

Founded in 2010, Pharmazz has raised 20.82 Mn+ in funding from a total number of 2 investors.

Pharmazz – Total Funding, Funding Over Time, Funding By Rounds and More.

Funding highlights of Pharmazz and a snapshot of its key metrics.

Sun Pharmaceutical Industries

Investment highlights of Pharmazz and a snapshot of its key metrics.

Pharmazz - A Health Tech Funded Company Based Out Of Noida

Pharmazz

A snapshot of highlights, scale, and metrics

A Health Tech Funded Company Based Out Of Noida

Pharmazz - Latest News, Analysis, Funding, Financials & More